MedTrace Logo

Evaluation of the Safety and Efficacy of an Acne Treatment Device

NCT06420804 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-05-20

No results posted yet for this study

Summary

A 50-patient study in which 400 microamps of direct current was applied 3 days per week. All tolerability, safety and efficacy endpoints were met.

Conditions

  • Mild to Moderate Acne

Interventions

DEVICE

ZIIP Acne Treatment Device

Evaluation of the Safety and Efficacy of a ZIIP Acne Treatment Device

Sponsors & Collaborators

  • Dermatology Consulting Services, PLLC

    collaborator NETWORK

  • ZIIP Beauty

    lead INDUSTRY

Principal Investigators

  • Zoe D Draelos, MD · Lead Investigator

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-15
Primary Completion
2021-09-01
Completion
2021-10-03
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06420804 on ClinicalTrials.gov